Polaris PeptidesSurvodutide
Ordered Survodutide from Polaris Peptides? Mail in a sample (US only) and let us test it for free.
Test my supplyPolaris Peptides' Survodutide evidence is pulled down by two same-day purity misses, 99.289% and 99.264%, after earlier 99.5%+ results. Identity passed and fills stayed within ±9%, leaving the post-Aug 2025 purity trajectory uncertain.
We investigated who actually operates Polaris Peptides — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Polaris Peptides rows.
Cancel anytime
About Polaris Peptides test results from Finnrick
Polaris Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 9 peptides and 107 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Polaris Peptides peptides in this dataset are BPC-157 (17 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 107 recent tests.
Ordered Survodutide from Polaris Peptides? Mail in a sample (US only) and let us test it for free.
Test my supply